國藥科技股份(08156.HK)：防偽產品年均商業合作數量累計超過2500萬個
格隆匯12月20日丨國藥科技股份(08156.HK)宣佈，受益於防偽業務團隊在積極開發新客户方面取得的成效，集團就提供國科防偽創新型防偽產品("國科防偽創新型防偽產品")累積所簽訂的商業合作數量平均每年超過2,500萬個，此數量再攀升至新高。這顯示出國科防偽創新型防偽產品的市場拓展工作在開拓新行業及深入滲透已有行業兩方面逐步實現共同提升的良好局面。集團相信，近段時間業務量的增加、以及隨着國科防偽創新型防偽產品開始落地交付而提升市場對產品的認受度，國科防偽創新型防偽產品的完整且良性的業務循環模式將為集團防偽業務帶來可持續增長。
國科防偽創新型防偽產品內含專利技術，主打"防偽"、"公信力"、"營銷"及"社會責任"四大特徵，採用全鏈路防偽體系，防偽包裝及線上防偽信息驗證平台構成國科防偽創新型防偽產品的核心。同時國科防偽創新型防偽產品在不同的應用場景中被賦予不同的功能和屬性，令本產品改寫傳統的防偽方式內涵，吸引用户積極參與防偽驗真。消費者透過"三碼合一"入口快捷進入線上防偽信息驗證平台，產品驗真和互動營銷等環節貫通，創造獨特營銷亮點。
目前，集團實踐防偽產品跨行業、跨區域商業化應用的策略初見成效。有見於國科防偽創新型防偽產品具備可複製商業模式特性，集團有信心繼續將國科防偽創新型防偽產品應用和深入覆蓋至各消費品領域。伴隨日漸豐富的與不同行業客户合作的經驗，總結各行業需求特徵及合作模式，為實現跨行業、跨區域目標打牢基礎，以鞏固市場地位。
國科防偽創新型防偽產品是協助達成企業社會責任的產品。集團將國科防偽創新型防偽產品作為幫助客户在企業社會責任方面實現更高水準的手段。國科防偽創新型防偽產品將企業社會責任中最為重要的其中兩個因素——消費者權益的保護及為社會公益及體育發展作出貢獻融入其產品內涵。同時運用國科防偽創新型防偽產品對品牌防偽保護及背書的能力，預期可支援品牌持續發展，達至對產業興旺、高品質發展，推動鄉村振興。企業用户通過使用國科防偽創新型防偽產品，將有效實現企業社會責任。國科防偽創新型防偽產品在各消費品中的廣泛應用，將企業社會責任的實現度推至新高。集團也將透過供應國科防偽創新型防偽產品實現及提升集團對企業社會責任事務的參與度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
